CD8A and neoplasm: Consistent with this, we observed that higher numbers of all CD8+ T-cells (Fig. 2) and of venus+ CD8+ T-cells (Fig. 3) in the tumor were well-associated with the suppression of tumor growth resulting from anti-PD-1/4-1BB or anti-CD4 mAb therapy.